Cargando…
Optimization of treatment with interferon beta in multiple sclerosis. Usefulness of automatic system application criteria
BACKGROUND: A software based tool has been developed (Optem) to allow automatize the recommendations of the Canadian Multiple Sclerosis Working Group for optimizing MS treatment in order to avoid subjective interpretation. METHODS: Treatment Optimization Recommendations (TORs) were applied to our da...
Autores principales: | Ruiz-Peña, Juan Luís, Duque, Pablo, Izquierdo, Guillermo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2292210/ https://www.ncbi.nlm.nih.gov/pubmed/18325088 http://dx.doi.org/10.1186/1471-2377-8-3 |
Ejemplares similares
-
Beta-interferons in multiple sclerosis
por: Aggarwal, Sourabh, et al.
Publicado: (2010) -
The real-world effectiveness and safety of fingolimod in relapsing-remitting multiple sclerosis patients: An observational study
por: Izquierdo, Guillermo, et al.
Publicado: (2017) -
‘Beta-interferons’ and ‘oligoclonal bands’ in multiple sclerosis in India
por: Hassan, K. M.
Publicado: (2011) -
Response to Interferon-Beta Treatment in Afro-Caribbeans with Multiple Sclerosis
por: Jeannin, S., et al.
Publicado: (2011) -
Beta‐interferon exposure and onset of secondary progressive multiple sclerosis
por: Zhang, T., et al.
Publicado: (2015)